Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESOBLAST LTD Capital/Financing Update 2024

Mar 25, 2024

31658_rns_2024-03-25_1ba2f61d-5cef-4846-b108-78a28163edbe.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [178 x 23] intentionally omitted <==

26 March 2024

The Manager Company Notices Section ASX Limited Level 4, North Tower, Rialto Towers 525 Collins Street MELBOURNE VIC 3000

Dear Sir/Madam

Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Mesoblast Limited (ABN 68 109 431 870) ( Mesoblast ) under section 708A(5)(e) of the Corporations Act 2001 (Cth) ( Corporations Act ).

Mesoblast has issued 3,100,000 fully paid ordinary shares in Mesoblast (the Shares ) to targeted institutional and professional investors.

Mesoblast advises that:

  • 1 the Shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

  • 2 this notice is being given under section 708A(5)(e) of the Corporations Act;

  • 3 as at the date of this notice, Mesoblast has complied with:

    • (a) the provisions of Chapter 2M of the Corporations Act, as they apply to Mesoblast; and

    • (b) sections 674 and 674A of the Corporations Act; and

  • 4 as at the date of this notice, Mesoblast is not aware of any excluded information in relation to Mesoblast for the purposes of sections 708A(7) and 708A(8) of the Corporations Act.

Release authorized by the Chief Executive.

Yours sincerely

==> picture [74 x 53] intentionally omitted <==

Paul Hughes Company Secretary Mesoblast Limited